Rifaximin for Infection Prophylaxis in Hematopoietic Stem Cell Transplantation
NCT03529825
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Microbial Colonization
Interventions
DRUG:
Rifaximin
Sponsor
Emory University